Lobbying client
RAPID MICRO BIOSYSTEMS, INC.
Identifying microbial contaminants in manufacture of drugs, medical devices, etc.
Filings
9
Filed by
1
Reported in-house
—
Reported by firms
$220,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2019 to 2021
Filings
9 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination 2nd Quarter 2021
|
BEACON STREET STRATEGIES, LLC | $20,000 reported |
|
1st Quarter - Report 1st Quarter 2021
|
BEACON STREET STRATEGIES, LLC | $30,000 reported |
|
4th Quarter - Report 4th Quarter 2020
|
BEACON STREET STRATEGIES, LLC | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
BEACON STREET STRATEGIES, LLC | $30,000 reported |
|
2nd Quarter - Report 2nd Quarter 2020
|
BEACON STREET STRATEGIES, LLC | $30,000 reported |
|
1st Quarter - Report 1st Quarter 2020
|
BEACON STREET STRATEGIES, LLC | $30,000 reported |
|
4th Quarter - Report 4th Quarter 2019
|
BEACON STREET STRATEGIES, LLC | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2019
|
BEACON STREET STRATEGIES, LLC | $20,000 reported |
|
Registration 3rd Quarter 2019
|
BEACON STREET STRATEGIES, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BEACON STREET STRATEGIES, LLC | 8 | $220,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Budget/Appropriations | BUD | 9 |
| Health Issues | HCR | 9 |
| Science/Technology | SCI | 9 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.